WA-AMAZON
Today Amazon (NASDAQ:AMZN) and National Safety Council (NSC) announced a five-year partnership to invent new ways to prevent the largest category of workplace injuries in the U.S., musculoskeletal disorders (MSDs). Amazon and NSC have been working together for months on this first-of-its-kind collaboration.
“Through this partnership we’ll be able to solve problems that people face every day so they can live their fullest lives,” said Lorraine Martin, president and CEO of National Safety Council. “Going to work should be a positive, rewarding, and safe experience. We are grateful for the generous support of Amazon to help companies around the world solve this important issue while fueling our nonprofit mission to keep employees safe in the workplace.”
"As a member of Amazon’s onsite safety team, my goal is to do everything I can to keep my fellow employees healthy at work so we all go home safe to our friends and families," said Chelsea Weimer, an hourly employee at Amazon’s fulfillment center in Baltimore, MD. "Amazon has a high standard for safety; this partnership is more proof of that and I can't wait to see the work that's done to help decrease MSDs."
The partnership will aim to prevent MSDs across a variety of industries by engaging key stakeholders, conducting research, inventing new technology and processes, and scaling the results. The collaboration is made possible by Amazon’s $12 million contribution, the largest corporate contribution in the history of NSC, and will include five key components:
Advisory Council: Establishing an international advisory council to bring together safety experts, corporations, and researchers in public and private sectors. The advisory council will work together to review the most promising approaches to MSD prevention, shape the development of partnership components, and engage external parties on MSD prevention.
Pioneering Research: Conducting research utilizing next-generation artificial intelligence, natural language processing, and machine learning tools to explore current and future MSD innovations and trends. The research will be available to all industries to explore and glean insights.
Small Business and University Grants: Providing grants to small businesses, universities, and university students. These grants will fund research and innovation that help companies of all sizes achieve impact.
Innovation Challenge: Incubating and fostering innovative and practical solutions to address MSDs through Innovation Challenge competitions. These competitions will bring together experts to collaborate, iterate, and share techniques and ideas.
Industry Call to Action – The MSD Pledge: Amazon and NSC will share solutions discovered throughout the partnership to inspire change through the creation of The MSD Pledge and a call on other companies to also join the effort to:
- Track proactive indicators of injuries to ensure proper risk mitigation and implement prevention strategies based on data.
- Implement an MSD prevention program that includes educating employees and employers about injury prevention.
- Embrace and drive forward innovative solutions to prevent MSDs and share best practices with other organizations worldwide.
The partnership kicks off in June during National Safety Month and in its first year will focus on launching the advisory council, identifying research partners, analyzing existing data, and developing the grant and Innovation Challenge programs.
“Nothing is more important than the safety of our employees, and this partnership will allow us to dive deep into the best way to reduce MSDs,” said Heather MacDougall, Amazon’s vice president of worldwide workplace health and safety. “National Safety Council has a long history of advancing safe practices in the workplace, and we look forward to working alongside them as well as many other businesses, experts, and students around the world to innovate and solve for this important issue.”
The NSC collaboration is another step in Amazon’s long-term mission to be Earth’s Safest Place to Work, which includes an investment of over $300 million into safety projects in 2021, and a goal to cut its recordable incident rate by 50% by 2025. Every day, Amazon works closely with health and safety experts, conducts thousands of safety inspections inside every building, and actively seeks employee feedback on how to improve their well-being at work. To see inside Amazon’s workplace and learn more about its team and technology, sign up for a fulfillment center tour at www.amazon.com/FCtours .
National Safety Council is America’s leading nonprofit safety advocate—and has been for over 100 years. As a mission-based organization, it works to eliminate the leading causes of preventable death and injury, focusing its efforts on the workplace, roadway, and impairment. It creates a culture of safety to keep people safer not only at work, but also beyond the workplace.
To learn more about employee safety at Amazon, visit www.amazon.com/employee-safety .
To learn more about the partnership, visit www.nsc.org/amazonpartnership .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005214/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
FieldBee Vision wins Gold for Digital Technology Innovation at LAMMA 20269.1.2026 05:25:00 CET | Press release
FieldBee, the European leader in high-quality, easy-to-use and affordable precision agriculture technologies, proudly announces that FieldBee Vision has earned global recognition, becoming the Gold Winner in the Digital Technology Innovation of the Year category at the LAMMA Innovation Awards 2026. Lamma Show is the UK’s premier agricultural machinery, technology and equipment innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107606411/en/ FieldBee wins the LAMMA Innovation Award 2026 for Digital Technology Innovation of the Year for the FieldBee Vision (VisionSteer & VisionPro) system FieldBee Vision is part of the newly launched myFieldBee ecosystem, built to unify FieldBee’s precision farming tools and designed to connect navigation, autosteering, ISOBUS into one unified platform that supports planning, execution, monitoring and reporting. FieldBee Vision, the first modular retrofit agricultural vision system,
Survey Finds Over 70% of Chinese Doctors Recommend “AI Doctor Services” Like Ant Group’s AQ for Everyday Health Needs9.1.2026 04:31:00 CET | Press release
A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) hospitals, more than 70% said they would recommend AI doctor services to patients for everyday health questions and routine health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108456917/en/ Ant Group’s AI-native health app AQ is designed to address common, everyday health concerns and support healthy habit formation. Ant Group’s AQ was the most frequently recommended platform in the survey. The latest figures show that, as of January 2026, the app had accumulated 30 million monthly active users and answers over 10 million health-related questions daily, making it China’s leading AI-native health app. AQ—known in Chinese as Ant A-Fu—is an AI-native health app launched by Ant Group in June 2025. Desig
OPPO Joins VVC Advance Patent Pool as a Licensee and Extends HEVC Advance License9.1.2026 03:00:00 CET | Press release
Access Advance LLC and Guangdong OPPO Mobile Telecommunications Corp., Ltd. (OPPO) today announced that OPPO has joined the VVC Advance Patent Pool as a Licensee and renewed its HEVC Advance License. OPPO, one of the world's largest smartphone manufacturers with operations in more than 70 countries, has been a valued participant in Access Advance's HEVC patent pool since 2020, and more recently joined the Advance Video Distribution Patent (VDP) Pool as a Licensor. These latest agreements mark a new milestone in a broad and deepening relationship between the two companies, with OPPO now participating across all three of Access Advance's video codec licensing programs. The VVC Advance Patent Pool licenses patents essential to the VVC/H.266 standard, which delivers remarkable improvement of video compression performance over HEVC, enabling higher-quality video experiences including 4K, 8K, and HDR content with faster downloads and lower latency. The pool currently includes over 4,500 worl
Cessna Citation CJ3 Gen2 Enters Into Service, Delivering the Most Significant Gen2 Updates to Date8.1.2026 22:30:00 CET | Press release
The Cessna Citation CJ3 Gen2 has entered into service, setting a new standard for the Citation Gen2 family. Launch customers and longtime Citation owners Dave Mecartney and Shannon Day took delivery of their new aircraft this week. Mecartney—an experienced aviator with nearly two decades flying Citation light jets and a member of Textron Aviation’s Customer Advisory Board—helped shape the enhancements that elevate the CJ3 Gen2 experience. Key upgrades include Garmin autothrottle technology, added pilot legroom and a fully customizable cabin environment, all driven by customer feedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108455097/en/ Cessna Citation CJ3 Gen2 enters into service, delivering the most significant Gen2 updates to date (Photo credit: Textron Aviation). The Cessna Citation CJ3 Gen2 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “The Citation CJ3 Gen2 deliv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
